Dr. Daniel Sterman Talks Phase 3 Mesothelioma Study on Podcast

Mesothelioma Guide’s newest podcast features the lead investigator into a promising Phase 3 mesothelioma clinical trial.

Dr. Daniel Sterman is the director of the Multidisciplinary Pulmonary Oncology Program at New York University Langone Health. He also is looking for participants in a progressed study that combines gene therapy and immunotherapy for pleural mesothelioma.



Sterman said this trial is an ongoing effort to “look at ways to stimulate the body’s own immune system” to fight mesothelioma.

“There are relatively few Phase 3 trials in mesothelioma,” Sterman said.

Mesothelioma Guide has published numerous articles about the clinical trial. On the podcast, Sterman gave a detailed summary of what the study hopes to accomplish.

Half of the 300 enrollees will receive the experimental treatment: an adenovirus-delivered Interferon Alpha-2B along with chemotherapy (Gemcitabine) and an arthritis pain medication (Celecoxib). The other half will receive just the chemotherapy drug and pain medicine.

“Many immunotherapies are drugs administered intravenously into the body,” Sterman said. “… There is a blockade in the tumor, and these drugs try to unleash that blockade.”

However, these immunotherapy drugs can go throughout the body. Therefore, they can be quite toxic to the patient.

Sterman’s trial, he explained, involves a virus transporting a gene into the location of the mesothelioma. Once the gene reaches the site, the tumors produce interferon-alpha. The production of this causes an immune system reaction.

“We are injecting a cold virus into the chest cavity of patients with mesothelioma,” Sterman said. This cold virus has been modified so that it can’t replicate itself. It also can’t cause the common cold.”

You may be eligible to participate in this clinical trial — or another study. Our patient advocate and registered nurse, Jenna Campagna, can help. Email her at jenna@mesotheliomaguide.com to learn the qualifications for this research.

Devin Golden

Devin Golden is the content writer for Mesothelioma Guide. He produces mesothelioma-related content on various mediums, including the Mesothelioma Guide website and social media channels. Devin's objective is to translate complex information regarding mesothelioma into informative, easily absorbable content to help patients and their loved ones.

Share
    Published by
    Devin Golden

    Recent Posts

    Can You Identify Each Mesothelioma Cell Type?

    Mesothelioma is a challenging disease to understand. The cancer is rare, largely unheard of, and doesn’t form on any well-known…

    18 hours ago

    Can You Have Both Pleural Mesothelioma and Peritoneal Mesothelioma?

    Almost all mesothelioma cases start in one of two areas: the pleura or the peritoneum. Hence, the two most common…

    2 days ago

    9/11-Related Mesothelioma Deaths Have Started

    In the aftermath of 9/11, medical experts worried about the long-term health ramifications. The people in lower Manhattan that day…

    1 week ago

    Lung Cancer Awareness Month: 10 Facts About Asbestos Lung Cancer

    Asbestos is a carcinogen linked to numerous diseases. If you’ve visited our website before, then you likely know the mineral…

    1 week ago

    Proton Radiation Surging as a Mesothelioma Treatment

    Experts continue exploring new treatment options for mesothelioma patients. Some ideas aren’t brand new but are tweaks to current forms…

    1 week ago

    Linking Automobile Work to Mesothelioma

    Have you ever thought of automobile brakes as a source of asbestos exposure and occupation linked to mesothelioma? If not,…

    2 weeks ago